Schering-Plough Clarinex Launch Strategy Follows Nexium Model

Schering-Plough's discounted pricing for the antihistamine Clarinex follows the model used by AstraZeneca to launch the anti-ulcer agent Nexium

More from Archive

More from Pink Sheet